Who
Judith Anne Shizuru
Director
Company insider
Files Form 4 as: Director, Jasper Therapeutics.
In numbers
- Trades disclosed
- 9
- Buys
- 1
- Sells
- 0
- Bought
- $100K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 21 Mar 2022
- Last trade
- 31 Jul 2026
- Last filed
- 4 Aug 2026
Companies traded
Activity over time
1 Sep 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 31 Jul 2026filed 4 Aug 2026 | JSPR Jasper Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,500 at $0.00 | filing |
| 31 Jul 2026filed 4 Aug 2026 | JSPR Jasper Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,500 at $0.00 | filing |
| 22 Sep 2025filed 24 Sep 2025 | JSPR Jasper Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code P | —41,000 | filing |
| 22 Sep 2025filed 24 Sep 2025 | JSPR Jasper TherapeuticsBiotechnology | SEC FORM 4 Bought | $100K41,000 at $2.43 | filing |
| 3 Jul 2025filed 3 Jul 2025 | JSPR Jasper Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,500 at $0.00 | filing |
| 6 Jun 2024filed 10 Jun 2024 | JSPR Jasper Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,500 at $0.00 | filing |
| 7 Jun 2023filed 8 Jun 2023 | JSPR Jasper Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —47,000 at $0.00 | filing |
| 12 Oct 2022filed 13 Oct 2022 | JSPR Jasper TherapeuticsBiotechnology | SEC FORM 4 Code A | —29,500 at $0.00 | filing |
| 21 Mar 2022filed 23 Mar 2022 | JSPR Jasper Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —78,045 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.